The interferon-stimulated gene 15 (ISG15) is a crucial therapeutic target for active tuberculosis and other comorbidities such as dermatomyositis, glioblastoma, psoriasis, hypertension, lung cancer, and breast cancer [58]. This evidence concerns the gene ISG15 and breast cancer.